Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 35Active not recruiting 7Unknown 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 86INDUSTRY 25NIH 4OTHER_GOV 1NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Conditions

Adenoma, Islet Cell 1

Interventions

Specimen Handling 39Magnetic Resonance Spectroscopy 30Carboplatin 14Biopsy 14Radiation 13Cyclophosphamide 13Radiotherapy 11daratumumab 10Vincristine 10Dexamethasone 10Surgical Procedures, Operative 9Etoposide 9Lenalidomide 8X-Rays 7Observation 7Leucovorin 7Irinotecan 7Doxorubicin 7Cisplatin 7durvalumab 6dexamethasone acetate 6dexamethasone 21-phosphate 6auricularum 6Watchful Waiting 6Radiosurgery 6Docetaxel 6Calcium Dobesilate 6pembrolizumab 5Stem Cell Transplantation 5Standard of Care 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × NETWORK × Temozolomide × Clear all
NCT05040360 2025-12-15

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

SWOG Cancer Research Network

Phase 2 Recruiting
141 enrolled

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡